Related Experiment Video

Updated: Jun 7, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity?

Brunangelo Falini1, Maria Paola Martelli, Niccolò Bolli

  • 1Institute of Hematology, University of Perugia, Ospedale S. Maria della Misericordia, S. Andrea delle Fratte, Perugia, Italy. faliniem@unipg.it

Blood
|October 30, 2010
PubMed

Insights

The NPM1 mutation is a primary driver in acute myeloid leukemia (AML), defining a distinct subtype. This genetic event impacts hematopoiesis and is usually exclusive of other mutations, influencing AML classification.

Area of Science:

  • Hematology
  • Molecular Biology
  • Oncology

Background:

  • NPM1-mutated acute myeloid leukemia (AML) was recognized in 2005 and provisionally classified by WHO in 2008.
  • Uncertainties remained regarding NPM1 mutation's role as a primary event and the impact of other genetic factors.

Purpose of the Study:

  • To clarify the role of NPM1 mutations as a founder genetic event in AML.
  • To determine the influence of chromosomal aberrations and multilineage dysplasia on NPM1-mutated AML.
  • To address the classification of AML with concurrent NPM1 and CEBPA mutations.

Main Methods:

  • Review of recent studies investigating NPM1 mutant's effect on hematopoiesis.
  • Analysis of leukemic stem cells in NPM1-mutated AML.
  • Examination of the mutual exclusivity of NPM1 and CEBPA mutations.

Main Results:

  • NPM1 mutations perturb hematopoiesis and are present in leukemic stem cells.
  • NPM1 mutations are typically mutually exclusive of biallelic CEBPA mutations.
  • Concomitant chromosomal aberrations or dysplasia do not significantly alter NPM1-mutated AML biology or prognosis.

Conclusions:

  • NPM1-mutated AML represents a distinct entity driven by a founder genetic event.
  • The NPM1 mutation is a key determinant in classifying approximately one-third of AML cases.
  • Further clarification of AML subtypes based on genetic drivers is essential for accurate classification and treatment.

More Related Videos

Comparative Lesions Analysis Through a Targeted Sequencing Approach08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor09:33

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Published on: August 25, 2023

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...